Affinity-purified human immunoglobulin G that binds a lacto-N-neotetraose- dependent lipooligosaccharide structure is bactericidal for serogroup B Neisseria meningitidis

Infection and Immunity

Volumn 75, Issue 2, 2007, Pages 1025-1033

  Estabrook, Michele M ^a,d   Jarvis, Gary A ^b,c   Griffiss, J McLeod ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; GLYCOLIPID; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; LACTO N NEOTETRAOSE; LIPOOLIGOSACCHARIDE; SEPHAROSE; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; SEROTYPE;

ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; CHROMATOGRAPHY, AFFINITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; LIPOPOLYSACCHARIDES; MICROBIAL VIABILITY; NEISSERIA MENINGITIDIS, SEROGROUP B; OLIGOSACCHARIDES; PROTEIN BINDING;

EID: 33846823037     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00882-06     Document Type: Article

References (55)

1. Apicella, M. A., J. F. Breen, and N. C. Gagliardi. 1978. Degradation of the polysaccharide component of gonococcal lipopolysaccharide by gonococcal and meningococcal sonic extracts. Infect. Immun. 20:228-234.
2. Bertram, M. A., J. M. Griffiss, and D. D. Broud. 1976. Response to antigenic determinants of Neisseria meningitidis lipopolysaccharide investigated with a new radioactive antigen-binding assay. J. Immunol. 116:842-846.
3. Bjune, G., E. A. Holby, J. K. Gronnesby, O. Arenesen, J. Fredriksen, A. Halstensen, E. Holten, and A. Lindbak. 1991. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338:1093-1096.
4. Boslego, J., J. Garcia, C. Cruz, W. Zollinger, B. Brandt, S. Ruiz, M. Martinez, J. Arthur, P. Underwood, W. Silva, E. Moran, W. Hankins, J. Gilly, and J. Mays. 1995. Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease. Vaccine 13:821-829.
5. Campos, L., J. Portoukalian, S. Bonnier, Z. Shi, P. Calmard-Oriol, D. Treille, and D. Guyotat. 1992. Specific binding of anti-N- acetyllactosamine monoclonal antibody 1B2 to acute myeloid leukemia cells. Eur. J. Cancer 28:37-41.
6. Cox, A. D., W. Zou, M. A. Gidney, S. Lacelle, J. S. Plested, K. Makepeace, J. C. Wright, P. A. Coull, E. R. Moxon, and J. C. Richards. 2005. Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: developmental chemistry and investigation of immunological responses following immunization of mice and rabbits. Vaccine 23:5045-5054.
7. De Moraes, J., B. A. Perkins, M. Camargo, N. Hildago, H. Barbosa, C. Sacchi, I. Landgraf, V. Gattas, H. Vasconcelos, J. Wenger, and C. V. Broome. 1992. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil. Lancet 340:1074-1078.
8. Estabrook, M. M., C. J. Baker, and J. M. Griffiss. 1993. The immune response of children to meningococcal lipooligosaccharides during disseminated disease is directed primarily against two monoclonal antibody-defined epitopes. J. Infect. Dis. 167:966-970.
9. Estabrook, M. M., N. C. Christopher, J. M. Griffiss, C. J. Baker, and R. E. Mandrell. 1992. Sialylation and human neutrophil killing of group C Neisseria meningitidis. J. Infect. Dis. 166:1079-1088.
10. Estabrook, M. M., J. M. Griffiss, and G. A. Jarvis. 1997. Sialylation of Neisseria meningitidis lipooligosaccharide inhibits serum bactericidal activity by masking lacto-N-neotetraose. Infect. Immun. 65:4436-4444.
11. Estabrook, M. M., D. L. Jack, N. J. Klein, and G. A. Jarvis. 2004. Mannose-binding lectin binds to two major outer membrane proteins, opacity protein and porin, of Neisseria meningitidis. J. Immunol. 172:3784-3792.
12. Estabrook, M. M., R. E. Mandrell, M. A. Apicella, and J. M. Griffiss. 1990. Measurement of the human immune response to meningococcal lipooligosaccharide antigens by using serum to inhibit monoclonal antibody binding to purified lipooligosaccharide. Infect. Immun. 58:2204-2213.
13. Estabrook, M. M., D. Zhou, and M. A. Apicella. 1998. Nonopsonic phagocytosis of group C Neisseria meningitidis by human neutrophils. Infect. Immun. 66:1028-1036.
14. Finne, M., A. Dell, J. Oates, P. Wu, J. Klock, and M. Fukuda. 1983. Antigenic similarities between brain components and bacteria causing meningitis. Lancet ii:355-357.
15. Gamian, A., M. Beurret, F. Michon, J. R. Brisson, and H. J. Jennings. 1992. Structure of the L2 lipopolysaccharide core oligosaccharides of Neisseria meningitidis. J. Biol. Chem. 267:922-925.
16. Gardi, A. 1984. Quality control in the production of an immunoglobulin for intravenous use. Blut 48:337-344.
17. Griffiss, J. M., B. L. Brandt, N. B. Saunders, and W. Zollinger. 2000. Structural relationships and sialylation among meningococcal L1, L8, and L3,7 lipooligosaccharide serotypes. J. Biol. Chem. 275:9716-9724.
18. Griffiss, J. M., B. L. Brandt, D. D. Broud, D. K. Goroff, and C. J. Baker. 1984. Immune response of infants and children to disseminated infections with Neisseria meningitidis. J. Infect. Dis. 150:71-79.
19. Griffiss, J. M., C. J. Lammel, J. Wang, N. P. Dekker, and G. F. Brooks. 1999. Neisseria gonorrhoeae coordinately uses pili and Opa to activate HEC-1-B cell microvilli, which causes engulfment of the gonococci. Infect. Immun. 67:3469-3480.
20. Griffiss, J. M., and H. Schneider. 1999. The chemistry and biology of lipooligosaccharides: the endotoxins of bacteria of the respiratory and genital mucosae, p. 179-194. In H. Brade, D. C. Morrison, S. Opal, and S. Vogel (ed.), Endotoxin in health and disease. Marcel Dekker, New York, NY.
21. Hayrinen, J., H. Jennings, H. V. Raff, G. Rougon, N. Hanai, R. Gerardy-Schahn, and J. Finne. 1995. Antibodies to polysialic acid and its N-propyl derivative: binding properties and interaction with human embryonal brain glycopeptides. J. Infect. Dis. 171:1481-1490.
22. John, C. M., J. M. Griffiss, M. A. Apicella, R. E. Mandrell, and B. W. Gibson. 1991. The structural basis for pyocin resistance in Neisseria gonorrhoeae lipooligosaccharides. J. Biol. Chem. 266:19303-19311.
23. Kahler, C. M., S. Lyons-Schindler, B. Choudhury, J. Glushka, R. W. Carlson, and D. S. Stephens. 2006. O-Acetylation of the terminal N-acetylglucosamine of the lipooligosaccharide inner core in Neisseria meningitidis: influence on inner core structure and assembly. J. Biol. Chem. 281:19939-19948.
24. Kahler, C. M., and D. S. Stephens. 1998. Genetic basis for biosynthesis, structure, and function of meningococcal lipooligosaccharide (endotoxin). Crit. Rev. Microbiol. 24:281-334.
25. Kogan, G., D. Uhrin, J. R. Brisson, and H. J. Jennings. 1997. Structural basis of the Neisseria meningitidis immunotypes including L4 and L7. Carbohydr. Res. 298:191-199.
26. Lee, F. K., D. S. Stephens, B. W. Gibson, J. J. Engstrom, D. Zhou, and M. A. Apicella. 1995. Microheterogeneity of Neisseria lipooligosaccharide: analysis of a UDP-glucose 4-epimerase mutant of Neisseria meningitidis NMB. Infect. Immun. 63:2508-2515.
27. Mandrell, R., J. Griffiss, and B. Macher. 1988. Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens: carbohydrate specificity of the mouse monoclonal antibodies that recognize cross-reacting antigens on LOS and human erythrocytes. J. Exp. Med. 168:107-126.
28. Mandrell, R. E., and W. D. Zollinger. 1989. Human immune response to meningococcal outer membrane protein epitopes after natural infection or vaccination. Infect. Immun. 57:1590-1598.
29. Mandrell, R. E., and W. D. Zollinger. 1977. Lipopolysaccharide serotyping of Neisseria meningitidis by hemagglutination inhibition. Infect. Immun. 16:471-475.
30. Mason, E. O., Jr., S. L. Kaplan, B. L. Wiedermann, E. P. Norrod, and W. A. Stenback. 1985. Frequency and properties of naturally occurring adherent piliated strains of Haemophilus influenzae type b. Infect. Immun. 49:98-103.
31. Milagres, L. G., S. R. Ramos, C. T. Sacchi, C. E. Melles, V. S. Vieira, H. Sato, G. S. Brito, J. C. Moraes, and C. E. Frasch. 1994. Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy. Infect. Immun. 62:4419-4424.
32. Perkins, B. A., K. Jonsdottir, H. Briem, E. Griffiths, B. D. Plikaytis, E. A. Hoiby, E. Rosenqvist, J. Holst, H. Nokleby, F. Sotolongo, G. Sierra, H. C. Campa, G. M. Carlone, D. Williams, J. Dykes, D. Kapczynski, E. Tikhomirov, J. D. Wenger, and C. V. Broome. 1998. Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland. J. Infect. Dis. 177:683-691.
33. Plested, J. S., M. Gidney, P. Coull, H. Griffiths, M. Herbert, A. G. Bird, J. Richards, and E. R. Moxon. 2000. Enzyme linked immunosorbent assay (ELISA) for the detection of serum antibodies to the core lipopolysaccharide of Neisseria meningitidis group B. J. Immunol. Methods 237:73-84.
34. Plested, J. S., A. Jakel, J. C. Wright, K. Makepeace, M. A. J. Gidney, S. Lacelle, F. St. Michael, W. Zou, A. D. Cox, J. C. Richards, and E. R. Moxon. 2004. Abstr. 14th Int. Pathog. Neisseria Conf., abstr. 187.
35. Romer, J., P. J. Spath, F. Skvaril, and U. E. Nydegger. 1982. Characterization of various immunoglobulin preparations for intravenous application. II. Complement activation and binding to staphylococcus protein A. Vox Sang. 42:74-80.
36. Rosenqvist, E., E. Hoiby, E. Wedege, K. Bryn, J. Kolberg, A. Klem, E. Ronnild, G. Bjune, and H. Nokleby. 1995. Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine. Infect. Immun. 63:4642-4652.
37. Rosenstein, N. E., B. A. Perkins, D. S. Stephens, T. Popovic, and J. M. Hughes. 2001. Meningococcal disease. N. Engl. J. Med. 344:1378-1388.
38. Ross, S. C., and P. Densen. 1984. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine 63:243-273.
39. Ross, S. C., and P. Densen. 1985. Opsonophagocytosis of Neisseria gonorrhoeae: interaction of local and disseminated isolates with complement and neutrophils. J. Infect. Dis. 151:33-41.
40. Schneider, H., A. S. Cross, R. A. Kuschner, D. N. Taylor, J. C. Sadoff, J. W. Boslego, and C. D. Deal. 1995. Experimental human gonococcal urethritis: 250 Neisseria gonorrhoeae MS11mkC are infective. J. Infect. Dis. 172:180-185.
41. Schneider, H., J. M. Griffiss, G. D. Williams, and G. B. Pier. 1982. Immunological basis of serum resistance of Neisseria gonorrhoeae. J. Gen. Microbiol. 128:13-22.
42. Schneider, H., T. L. Hale, W. D. Zollinger, R. Seid, Jr., C. A. Hammack, and J. M. Griffiss. 1984. Heterogeneity of molecular size and antigenic expression within lipooligosaccharides of individual strains of Neisseria gonorrhoeae and Neisseria meningitidis. Infect. Immun. 45:544-549.
43. Sierra, G., H. Campa, N. Varacel, I. Garcia, P. Izquierdo, P. Sotolongo, G. Casanueva, C. Rico, C. Rodriquez, and M. Terry. 1991. Vaccine against group B Neisseria meningitis: protection trial and mass vaccination results in Cuba. NIPH Ann. 14:195-207.
44. Stephens, D. S., C. F. McAllister, D. Zhou, F. K. Lee, and M. A. Apicella. 1994. Tn916-generated lipooligosaccharide mutants of Neisseria meningitidis and Neisseria gonorrhoeae. Infect. Immun. 62:2947-2952.
45. Swanson, K. V., and J. M. Griffiss. 2006. Separation and identification of neisserial lipooligosaccharide oligosaccharides using high-performance anion-exchange chromatography with pulsed amperometric detection. Carbohydr. Res. 341:388-396.
46. Swanson, K. V., G. A. Jarvis, G. F. Brooks, B. J. Barham, M. D. Cooper, and J. M. Griffiss. 2001. CEACAM is not necessary for Neisseria gonorrhoeae to adhere to and invade female genital epithelial cells. Cell. Microbiol. 3:681-691.
47. Symington, F. W., D. L. Hedges, and S. Hakomori. 1985. Glycolipid antigens of human polymorphonuclear neutrophils and the inducible HL-60 myeloid leukemia line. J. Immunol. 134:2498-2506.
48. Takayama, K., N. Qureshi, K. Hyver, J. Honovich, R. Cotter, P. Mascagni, and H. Schneider. 1986. Characterization of a structural series of lipid A obtained from the lipopolysaccharides of Neisseria gonorrhoeae. J. Biol. Chem. 261:10624-10631.
49. Tappero, J. W., R. Lagos, A. M. Ballesteros, B. Plikaytis, D. Williams, J. Dykes, L. L. Gheesling, G. M. Carlone, E. A. Hoiby, J. Holst, H. Nokleby, E. Rosenqvist, G. Sierra, C. Campa, F. Sotolongo, J. Vega, J. Garcia, P. Herrera, J. T. Poolman, and B. A. Perkins. 1999. Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile. JAMA 281:1520-1527.
50. Yamasaki, R., T. Maruyama, U. Yabe, and S. Asuka. 2005. Normal human sera contain bactericidal IgG that binds to the oligosaccharide epitope expressed within lipooligosaccharides of Neisseria gonorrhoeae. J. Biochem. 137:487-494.
51. Yamasaki, R., W. Nasholds, H. Schneider, and M. A. Apicella. 1991. Epitope expression and partial structural characterization of F62 lipooligosaccharide (LOS) of Neisseria gonorrhoeae: IgM monoclonal antibodies (3F11 and 1-1-M) recognize non-reducing termini of the LOS components. Mol. Immunol. 28:1233-1242.
52. Yamasaki, R., H. Schneider, J. M. Griffiss, and R. Mandrell. 1988. Epitope expression of gonococcal lipooligosaccharide (LOS). Importance of the lipoidal moiety for expression of an epitope that exists in the oligosaccharide moiety of LOS. Mol. Immunol. 25:799-809.
53. Young, W. W. J., J. Portoukalian, and S. Hakomori. 1981. Two monoclonal anticarbohydrate antibodies directed to glycosphingolipids with a lacto-N-glycosyl type II chain. J. Biol. Chem. 21:10967-10972.
54. Zollinger, W. D., R. E. Mandrell, J. M. Griffiss, P. Altieri, and S. Berman. 1979. Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man. J. Clin. Investig. 63:836-848.
55. Zollinger, W. D., J. G. Babcock, J. B. Berman, B. L. Brandt, E. E. Moran, N. M. Wassif, and C. R. Alving. 2004. Abstr. 14th Int. Pathog. Neisseria Conf., abstr. 200.